BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36853322)

  • 1. Neutrophil-to-Lymphocyte Ratio (NLR) for Preoperative Differentiation between Uterine Leiomyosarcoma (LMS) and Uterine Leiomyoma: A Case-Controlled Study.
    Srisutha P; Santibenchakul S; Ariyasriwatana C; Oranratanaphan S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):701-707. PubMed ID: 36853322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma.
    Suh DS; Song YJ; Roh HJ; Lee SH; Jeong DH; Lee TH; Choi KU; Kim KH
    Cancer Manag Res; 2021; 13():5001-5011. PubMed ID: 34211296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
    Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
    Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
    Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
    BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
    Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.
    Lakhman Y; Veeraraghavan H; Chaim J; Feier D; Goldman DA; Moskowitz CS; Nougaret S; Sosa RE; Vargas HA; Soslow RA; Abu-Rustum NR; Hricak H; Sala E
    Eur Radiol; 2017 Jul; 27(7):2903-2915. PubMed ID: 27921159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of multiparametric MRI in differentiating uterine leiomyosarcoma from benign degenerative leiomyoma and leiomyoma variants: a retrospective analysis.
    Mahmood NS; Al Rashid AA; Ladumor SB; Mohamed MA; Kambal AS; Saloum N; Mohamed SEMK; Al Hyassat S; Singh R
    Clin Radiol; 2023 Jan; 78(1):47-54. PubMed ID: 36220736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
    Skorstad M; Kent A; Lieng M
    Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics.
    Cho HY; Kim K; Kim YB; No JH
    J Obstet Gynaecol Res; 2016 Mar; 42(3):313-8. PubMed ID: 26695124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
    Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
    Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
    J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil to lymphocyte ratio as an assessment tool to differentiate between uterine sarcoma and myoma: a systematic review and meta-analysis.
    Tabatabaei F; Babadi S; Nourigheimasi S; Ghaedi A; Khanzadeh M; Bazrgar A; Gargari MK; Khanzadeh S
    BMC Cancer; 2024 Jan; 24(1):12. PubMed ID: 38166889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.
    Lintel NJ; Luebker SA; Lele SM; Koepsell SA
    Hum Pathol; 2018 Mar; 73():122-127. PubMed ID: 29307622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system.
    Jagannathan JP; Steiner A; Bay C; Eisenhauer E; Muto MG; George S; Fennessy FM
    Abdom Radiol (NY); 2021 Oct; 46(10):4927-4935. PubMed ID: 34075468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
    Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
    Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.
    Sparić R; Andjić M; Babović I; Nejković L; Mitrović M; Štulić J; Pupovac M; Tinelli A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign uterine mass-discrimination from leiomyosarcoma by a preoperative risk score: a multicenter cohort study.
    Köhler G; Vollmer M; Nath N; Hessler PA; Dennis K; Lehr A; Köller M; Riechmann C; Bralo H; Trojnarska D; Lehnhoff H; Krichbaum J; Krichbaum M; Evert K; Evert M; Zygmunt M; Kaderali L
    Arch Gynecol Obstet; 2019 Dec; 300(6):1719-1727. PubMed ID: 31677088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.